ORAGENICS, INC. Accrued Vacation, Current
ORAGENICS, INC. (OGEN) had Accrued Vacation, Current of $8.40 thousand as of 2024-12-31, per its 10-K filed 2025-03-14.
Financial Statements › Notes › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccruedVacationCurrent · last filed 2025-03-14
- 2024-12-31: Accrued Vacation, Current $8.40K.
- 2024-09-30: Accrued Vacation, Current $28.17K.
- 2024-06-30: Accrued Vacation, Current $21.93K.
- 2024-03-31: Accrued Vacation, Current $17.29K.
| Period end | Accrued Vacation, Current | Accrued Vacation, Current as first filed |
|---|---|---|
| 2024-12-31 | $8.40K 10-K · filed 2025-03-14 | |
| 2024-09-30 | $28.17K 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $21.93K 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $17.29K 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $7.98K 10-K · filed 2025-03-14 | |
| 2023-09-30 | $30.14K 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $26.00K 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $43.12K 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $33.55K 10-K · filed 2024-03-29 | |
| 2021-12-31 | $57.73K 10-K · filed 2023-04-17 | |
| 2020-12-31 | $158.72K 10-K/A · filed 2022-07-29 | |
| 2019-12-31 | $143.09K 10-K · filed 2021-03-01 | |
| 2018-12-31 | $123.27K 10-K · filed 2020-03-04 | |
| 2017-12-31 | $106.72K 10-K · filed 2019-03-29 | |
| 2016-12-31 | $93.36K 10-K · filed 2018-02-16 | |
| 2015-12-31 | $67.92K 10-K · filed 2017-02-27 | $87.62K 10-K · filed 2016-03-30 |
| 2014-12-31 | $77.78K 10-K · filed 2016-03-30 | |
| 2013-12-31 | $85.30K 10-K · filed 2015-02-27 | |
| 2012-12-31 | $54.05K 10-K · filed 2014-02-28 | |
| 2011-12-31 | $85.66K 10-K · filed 2013-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |